Correspondence  |   June 1998
Safety of Patient-controlled Intravenous Meperidine
Author Notes
  • Clinical Fellow (Wilson)
  • Head; Department Anaesthesia; BC Women's Hospital; Vancouver, Canada (Douglas)
Article Information
Correspondence   |   June 1998
Safety of Patient-controlled Intravenous Meperidine
Anesthesiology 6 1998, Vol.88, 1688-1689. doi:
Anesthesiology 6 1998, Vol.88, 1688-1689. doi:
To the Editor:- We would like to congratulate Sharma et al. [1] on the results of their study examining the relationship between cesarean section and epidural analgesia during labor in which they address the problem of “labor pain selection bias.” This current study addressed many of the concerns that were raised with their previous study. [2] 
We would like to express concern, however, regarding their conclusion that “we found meperidine PICA to be a safe and effective method of pain relief.”[1] On what basis was this conclusion made? When the two groups were compared in terms of maternal satisfaction, pain scores in the first and second stages of labor, maternal desire for the same form of analgesia, and maternal sedation, the epidural group was significantly superior on all accounts. Perhaps they believed that there was a smaller crossover from the PCIA group to the epidural group, in contrast to their previous study; this suggested that the PCIA group had effective analgesia. Because the thrust of this study by caregivers and investigators was to keep patients in their original group, this may also have contributed to the sense that adequate analgesia was provided. The statistically significant difference between the two groups in respect to maternal satisfaction and desire for the same form of analgesia again cannot be ignored.
On the issue of safety, Chestnut in his accompanying editorial makes the following comment, “Maternal administration of high doses of opioids may result in substantial neonatal effects (e.g., respiratory depression, prolonged neurobehavioral changes). These factors have been largely ignored in this debate.”[3] Neonatal safety in this study was examined using Apgar scores, umbilical artery gases, naloxone requirements, and intensive care admission. There was a statistically significant difference between the groups in the use of naloxone. Differences for the other parameters of neonatal outcome failed to reach statistical significance, although there is no evidence presented that this study had the power to examine this question, and it would be wrong to draw firm conclusions. It would have been valuable if the authors had examined neonatal neurobehavioral changes in the two groups. There is a large body of evidence that meperidine used for labor analgesia causes significant neurobehavioral effects. [4–8] Many of these studies involved lower doses than those used in this study. The clinical significance of these more subtle changes in neonatal behavior are not clearly defined, but when considering neonatal safety, these effects should not be ignored.
In conclusion, we agree with the authors that “labor epidural analgesia in women at full term with uncomplicated pregnancies and in spontaneous active labor is not associated with increased numbers of cesarean delivery.”[1] However, until there is further evidence as to the safety of PCIA meperidine, particularly on the neonate, we do not think it should be considered a safe and effective method of pain relief during labor.
Deborah Wilson
Clinical Fellow
M. Joanne Douglas
Head; Department Anaesthesia; BC Women's Hospital; Vancouver, Canada
Sharma SK, Sidawi JE, Ramin SM, Lucas MJ, Leveno KJ, Cunningham FG: Cesarean delivery. A randomized trial of epidural versus patient-controlled meperidine analgesia during labor. Anesthesiology 1997; 87:487-94
Ramin SH, Gambling DR, Lucas MJ, Sharma SK, Sidawi JE, Leveno KJ: Randomized trial of epidural versus intravenous analgesia during labor. Obstet Gynecol 1995; 86:783-9
Chestnut DH: Epidural analgesia and the incidence of cesarean section. Anesthesiology 1997; 87:472-6
Kuhnert BR, Linn PL, Kennard MJ, Kuhnert PM: Effects of low dose meperidine on neonatal behavior. Anesth Analg 1985; 64:335-42
Hodgkinson R, Husain FJ: The duration of effects of maternally administered meperidine on neonatal neurobehavior. Anesthesiology 1982; 56:51-2
Hodgkinson R, Bhatt M, Wang CN: Double-blind comparison of the neurobehaviour of neonates following the administration of different doses of meperidine to the mother. Can Anaesth Soc J 1978; 25:405-11
Brackbill Y, Kane J, Manniello RL, Abramson D: Obstetric meperidine usage and assessment of neonatal status. Anesthesiology 1974; 40:116-20
Wiener PC, Hogg MI, Rosen M: Neonatal respiration, feeding and neurobehavioural state: Effects of intrapartum bupivacaine, pethidine and pethidine reversed by naloxone. Anaesthesia 1997; 34:996-1004